Accounts Receivables - LeMaitre Vascular Inc (NASDAQ:LMAT) - Alpha Spread

Watchlist Manager

Watchlist

Price: 78.88 USD 0.14%

Updated:

LeMaitre Vascular Inc
Accounts Receivables

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

LeMaitre Vascular Inc
Accounts Receivables Peer Comparison

BDX

BSX

SYK

ABT

ISRG

Company		Accounts Receivables	CAGR 3Y	CAGR 5Y	CAGR 10Y
	LeMaitre Vascular Inc NASDAQ:LMAT	Accounts Receivables $30.2m	CAGR 3-Years 15%	CAGR 5-Years 14%	CAGR 10-Years 11%
	Becton Dickinson and Co NYSE:BDX	Accounts Receivables $2.6B	CAGR 3-Years 7%	CAGR 5-Years 2%	CAGR 10-Years 9%
	Boston Scientific Corp NYSE:BSX	Accounts Receivables $2.3B	CAGR 3-Years 12%	CAGR 5-Years 7%	CAGR 10-Years 7%
	Stryker Corp NYSE:SYK	Accounts Receivables $3.5B	CAGR 3-Years 10%	CAGR 5-Years 9%	CAGR 10-Years 9%
	Abbott Laboratories NYSE:ABT	Accounts Receivables $6.6B	CAGR 3-Years 3%	CAGR 5-Years 4%	CAGR 10-Years 5%
	Intuitive Surgical Inc NASDAQ:ISRG	Accounts Receivables $1.1B	CAGR 3-Years 20%	CAGR 5-Years 16%	CAGR 10-Years 17%

See Also

Based on the financial report for Mar 31, 2024, LeMaitre Vascular Inc's Accounts Receivables amounts to 30.2m USD.

Over the last year, the Accounts Receivables growth was 19%. The average annual Accounts Receivables growth rates for LeMaitre Vascular Inc have been 15% over the past three years , 14% over the past five years , and 11% over the past ten years .

Join more than 142,700+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.